drugset / Trial / NCT01986309

Intravenous Lidocaine in the Prevention of Postoperative Vomiting in Elective Tonsil Surgery

NCT01986309 ↗

Phase 4 Completed 92 enrolled Pontificia Universidad Catolica de Chile
RandomizedParallel-groupTriple-blindTreatment

Summary

There some evidence regarding the effect of lidocaine for the prevention of nausea and vomiting in adults.

Timeline

Start
2012-03
Primary completion
2013-06
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 2 mg/kg Intravenous

Indications

No indication recorded.